Belsomra 20 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FJ3T0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,071
Award facts
- Contract value 100% obligated
- $1,070.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,070.75 to AmerisourceBergen Drug Corp for the supply of Belsomra 20 mg tablets (30 count) on December 3, 2025, with completion expected by December 4, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded transaction under DLA's broader pharmaceutical procurement framework. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations for federal medical supply contracts.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement that extends through December 2026 and serves as the primary vehicle for pharmaceutical and medical supply distribution to military healthcare systems globally. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant position within the federal supply chain for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, from specialty medications to vaccines and medical devices, supporting military and veteran healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FJ3T0?
SPE2DR26FJ3T0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FJ3T0 worth?
The government has obligated $1,071 on SPE2DR26FJ3T0.
Is contract SPE2DR26FJ3T0 an order under another contract?
Yes. SPE2DR26FJ3T0 is a delivery order under SPE2DR25D2009, an indefinite delivery contract.
Was contract SPE2DR26FJ3T0 competed?
The extent of competition for SPE2DR26FJ3T0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award